Sr. Manager, Strategy - Oncology & Multispecialty

McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. We are known for delivering insights, products, and services that make quality care more accessible and affordable. Here, we focus on the health, happiness, and well-being of you and those we serve - we care. What you do at McKesson matters. We foster a culture where you can grow, make an impact, and are empowered to bring new ideas. Together, we thrive as we shape the future of health for patients, our communities, and our people. If you want to be part of tomorrow's health today, we want to hear from you. This role offers location flexibility and is open to candidates across the United States. Candidates based in the Dallas-Fort Worth (DFW) area will be hired in a hybrid capacity and are expected to work onsite at our Las Colinas office a minimum of two (2) days per week, with the remaining days worked remotely. Specific inoffice days may be designated based on team needs and business priorities. About The Role: The Sr. Manager, Strategy - Oncology & Multispecialty is an analytical individual contributor role within the strategy team, supportingthe developmentofframeworks, models, and researchthat enable the evaluation and execution of key strategicinitiatives.Initiatives spanbothcommercial segments - provider-facing (GPO, specialty distribution, specialty pharmacy, alternate site infusion, practice management) and biopharma-facing (clinical trial site management, real-world evidence, clinicogenomic data) - and frequently sit at the intersection between the two, where the segment's most distinctive strategic questions live. TheSr. Manager will be expected toindependently and comprehensively develop an analytical model that supports each initiative andcomplete required analysis and research required to enable leadership to make informed decisions and develop a path forward.Taking responsibility for accuracy andcompleteness,the senior managerwill be expectedtobring their own thoughts and perspectives tothe analyticalprocess to ensureeffective evaluation ofinitiatives. What You'll Do: Strategic Analysis & Insight - Own end-to-end analytical workstreams within larger strategic initiatives - from problem structuring and hypothesis development through analysis and synthesis of findings - with guidance from initiative leads. - Build rigorous fact basesincludingon market structureand trending, competitor strategies and economics, practiceand providersegmentation,commercialization opportunities,and biopharma demand across both the provider-facing and biopharma-facing franchises. - Synthesize complex quantitative and qualitative information into clear, well-structured storylines; consistently deliver the "so what," not just the analysis. - Identify implications of your own workstream for the overall initiative, and flag issues and opportunities to initiative leadership proactively. Specialty Value Chain & Financial Analysis Build and maintain financial models that translate market shifts - reimbursement changes, biosimilar entry, site-of-care dynamics, practice consolidation, biopharma R&D spending shifts - into quantified P&L implications, with review from senior team members. Develop working knowledge of how participants in the specialty care value chain - biopharma manufacturers, GPOs, distributors, specialty pharmacies, payers, providers, CROs, and RWE and data companies - earn and protect economic value. Track and analyze regulatory and policy developments - 340B reform, Medicare Part B drug reimbursement, oncology care model evolution,FDA policy on real-world evidenceas examples- and support the assessment of their implications. Support scenario and sensitivity analysis: pressure-test th